🌍 Join our mission
📢 Request for Proposals – Feasibility and Concept Design Expert – GMP mRNA Vaccine Manufacturing in Africa
📢 Request for Proposals – GLP1-RA Market Assessment for Obesity Treatment.
📢 Board Member Opportunity
👉 medicinespatentpool.org/who-we-are/c...
"Expanding our licence with ViiV Healthcare to include long-acting cabotegravir for #HIV treatment marks a significant step forward for equitable access”
- @medicinespatentpool.org's Esteban Burrone 🇨🇭 #IAS2025
The MPP and ViiV have expanded their agreement to now include cabotegravir long-acting for both #HIV prevention and treatment.
This is the first fully long-acting HIV treatment made available through a voluntary licence in low- and middle- income countries.
#IAS2025 #ViiV #Unitaid
Ahead of #WorldIPDay, we’re launching the #MedsPaL Tutorial Series, your guide to navigating MPP’s patents and licences database 🌍💊
🔍 Learn how to perform a basic search, explore #patent results, and access licence and #data exclusivity information!
👉 www.youtube.com/watch?v=JPlW...
www.medspal.org
"Our teams in the Democratic Republic of Congo say that they have not received antiretroviral supplies at the MSF-run CHK Hospital in Kinshasa since 20 January, leaving over 2,000 HIV/TB patients at risk of developing drug resistance, advanced HIV and dying,if supplies are not resumed immediately."
📢 MPP & @lstmnews.bsky.social signed a MOU to enhance global access to LSTM’s IP portfolio. 🌍✨
🙌 This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.
🔗 bit.ly/40eQYDt
Some positive news for a change re: Global Health funding, as #Canada announces a pledge of $675 million over the next five years (2026-2030) for #Gavi, The Vaccine Alliance. www.canada.ca/en/global-af...
www.lemonde.fr/idees/articl...
Celebrating #WorldAIDSDay2024 with insights from Nelson Otwoma, Director of NEPHAK. Discover Kenya's journey in #HIV treatment, the impact of access to dolutegravir through voluntary licensing & the support of many partners & ongoing efforts to improve the lives of those affected.
bit.ly/4eU9Ahp
